EUVIMEDEUVIMED entdecken
Open Access

False-positive magnetic resonance imaging prostate cancer correlates and clinical implications

Mostafa A Arafa, Danny M Rabah, Farrukh Khan, Karim Hamda Farhat, Nahla Khamis Ibrahim, Alanoud A Albekairi

Urology Annals · 2023-01 · 15 (1) · 54-59

DOI: 10.4103/ua.ua_22_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urology Annals, online erschienen am 08.11.2022. Verfasst von Mostafa A Arafa und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Cancer Research Chair, King Saud University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

False-positive (FP) multiparametric magnetic resonance imaging (MPMRI) obscures and swift needless biopsies in men with a high prostate-specific antigen. Materials and Methods: This was a retrospective study, in which all patients who had been exposed to consecutive MP-MRI of the prostate combined with transrectal ultrasound-guided-magnetic resonance imaging fusion-guided prostate biopsy between 2017 and 2020 were involved in the study. The FP was measured as the number of biopsies that did not encompass prostate cancer divided by the whole number of biopsies.

Results

The percentage of FP cases was 51.1%, the highest percentage was found in Prostate Imaging–Reporting and Data System (PI-RADs) 3 (37.7%) and the lowest was detected in PI-RAD 5 (14.5%). Those with FP biopsies are younger, and their total prostate antigen (PSA) and PSA density (PSAD) are significantly lesser. The area under the curve PSAD, age, and total PSA are 0.76, 0.74, and 0.69, respectively. An optimum PSAD value of 0.135 was chosen as a cutoff because it showed the highest sum of sensitivity and specificity, 68% and 69%, respectively.

Conclusion

FP results of mpMRI were detected in more than half of our sample, more than one-third were presented in Pi-RAD3, improved imaging techniques to decrease FP rates are highly needed.

Schlagwörter

Stichwörter der Autor:innen

PIRADsprostate cancertransrectal ultrasound-guided biopsy- magnetic resonance imaging fusion-guided…

Autor:innen und Institutionen

  • The Cancer Research Chair, King Saud University, Riyadh, Saudi Arabia.
  • Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
  • Departemnet of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Community Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Medical Student at the College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Zitieren

APA

Arafa, M. A., Rabah, D. M., Khan, F., Farhat, K. H., Ibrahim, N. K., & Albekairi, A. A. (2023). False-positive magnetic resonance imaging prostate cancer correlates and clinical implications. Urology Annals, 15(1), 54-59. https://doi.org/10.4103/ua.ua_22_22

Vancouver

Arafa MA, Rabah DM, Khan F, Farhat KH, Ibrahim NK, Albekairi AA. False-positive magnetic resonance imaging prostate cancer correlates and clinical implications. Urology Annals. 2023;15(1):54-59. doi:10.4103/ua.ua_22_22

BibTeX
@article{Arafa2023,
  author = {Arafa, Mostafa A and Rabah, Danny M and Khan, Farrukh and Farhat, Karim Hamda and Ibrahim, Nahla Khamis and Albekairi, Alanoud A},
  title = {False-positive magnetic resonance imaging prostate cancer correlates and clinical implications},
  journal = {Urology Annals},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {54--59},
  doi = {10.4103/ua.ua_22_22}
}
Kostenlos starten →